Evidence map›Paper›PMID 32562794›Full record

SynthesisThe Journal of infection2020

Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors.

Emma L Smith, India Wheeler, Hugh Adler, Daniela M Ferreira, Raquel Sá-Leão, Osman Abdullahi, Ifedayo Adetifa, Sylvia Becker-Dreps, Susanna Esposito, Helmia Farida and 18 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Molecular Epidemiology ofInternational journal of molecular sciences · 2025
    Pooled it
  2. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Guideline
  3. Trial
  4. Article
  5. Article
  6. Bacterial and host factors affecting acquisition ofbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. mSphere · 2025
    Observational
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of AcquiringInternational journal of chronic obstructive pulmonary disease · 2023
    Article
  18. Article
  19. Article
  20. Neutrophil Recruitment in Pneumococcal Pneumonia.Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 19 institutions in 14 countries.

Emma L SmithDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
India WheelerDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Hugh AdlerDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Daniela M FerreiraDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Raquel Sá-LeãoInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Osman AbdullahiDepartment of Public Health, School of Health and Human Sciences, Pwani University, Kilifi, Kenya.
Ifedayo AdetifaEpidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, WC1E 7HT, London, United Kingdom; Department of Paediatrics and Child Health, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria.
Sylvia Becker-DrepsDepartments of Family Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Susanna EspositoPediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy.
Helmia FaridaFaculty of Medicine, Diponegoro University, Semarang, Indonesia.
Rama KandasamyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LE, United Kingdom; NIHR Oxford Biomedical Research Centre, Oxford OX3 7LE, United Kingdom.
Grant A MackenzieMedical Research Council The Gambia Unit at LSHTM, Banjul, The Gambia; Faculty of Infectious and Tropical Diseases, The London School of Hygiene & Tropical Medicine, United Kingdom; Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia.
J Pekka NuortiHealth Sciences Unit, Faculty of Social Sciences, Tampere University, Finland; Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
Susan NzenzeMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa.
Omar OrtegaGastrointestinal Physiology Laboratory, Department of Surgery, Hospital de Mataró, Universitat Autónoma de Barcelona, Mataró, Spain; Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas (CIBERehd), Instituto de Salud Carlos III, Barcelona, Spain.
Anna RocaMedical Research Council The Gambia Unit at LSHTM, Banjul, The Gambia.
Dodi SafariEijkman Institute for Molecular Biology, Jl. Diponegoro no. 69 Jakarta, Indonesia.
Frieder SchaumburgInstitute of Medical Microbiology, University Hospital Muenster, Muenster, Germany.
Effua UsufMedical Research Council The Gambia Unit at LSHTM, Banjul, The Gambia.
Elisabeth A M SandersDepartment of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.
Lindsay R GrantDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Laura L HammittDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Katherine L O'BrienDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Prabhu GounderArctic Investigations Program, Division of Preparedness and Emerging Infections, Center for Disease Control and Prevention, Anchorage, Alaska.
Dana J T BrudenArctic Investigations Program, Division of Preparedness and Emerging Infections, Center for Disease Control and Prevention, Anchorage, Alaska.
Michelle C StantonLancaster Medical School, Lancaster University, United Kingdom.
Jamie RylanceDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Electronic address: Jamie.Rylance@lstmed.ac.uk.
Liverpool School of Tropical Medicine · GBJohns Hopkins University · USMRC Unit the Gambia · GMDiponegoro University · IDEijkman Institute for Molecular Biology · IDFinnish Institute for Health and Welfare · FIInstituto de Salud Carlos III · ESLancaster University · GBMurdoch Children's Research Institute · AUNational Research Foundation · ZAPwani University · KEUniversidade Nova de Lisboa · PTUniversity Hospital Münster · DEUniversity of London · GBUniversity of North Carolina at Chapel Hill · USUniversity of Oxford · GBUniversity of Perugia · ITUniversity of the Witwatersrand · ZAWilhelmina Children's Hospital · NL

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundColonisation with Streptococcus pneumoniae can lead to invasive pneumococcal disease and pneumonia. Pneumococcal acquisition and prevalence of colonisation are high in children. In older adults, a population susceptible to pneumococcal disease, colonisation prevalence is reported to be lower, but studies are heterogeneous.

methodsThis is a systematic review and meta-analysis of prevalence of, and risk factors for, pneumococcal colonisation in adults ≥ 60 years of age (PROSPERO #42016036891). We identified peer-reviewed studies reporting the prevalence of S. pneumoniae colonisation using MEDLINE and EMBASE (until April 2016), excluding studies of acute disease. Participant-level data on risk factors were sought from each study.

findingsOf 2202 studies screened, 29 were analysable: 18 provided participant-level data (representing 6290 participants). Prevalence of detected pneumococcal colonisation was 0-39% by conventional culture methods and 3-23% by molecular methods. In a multivariate analysis, colonisation was higher in persons from nursing facilities compared with the community (odds ratio (OR) 2•30, 95% CI 1•26-4•21 and OR 7•72, 95% CI 1•15-51•85, respectively), in those who were currently smoking (OR 1•69, 95% CI 1•12-2•53) or those who had regular contact with children (OR 1•93, 95%CI 1•27-2•93). Persons living in urban areas had significantly lower carriage prevalence (OR 0•43, 95%CI 0•27-0•70).

interpretationOverall prevalence of pneumococcal colonisation in older adults was higher than expected but varied by risk factors. Future studies should further explore risk factors for colonisation, to highlight targets for focussed intervention such as pneumococcal vaccination of high-risk groups.

fundingNo funding was required.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeAgedCarrier StateChildHumansMiddle AgedNasopharynxPneumococcal VaccinesPrevalenceRisk FactorsPneumococcal VaccinesPneumococcal;  Colonisation;  Adults;  Risk factors

Identifiers

PMID32562794
PMCPMC7532703
OpenAlexW3036786163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.